Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immunotherapy of Neuromyelitis Optica.
Spring cleaning: time to rethink imaging research lines in MS?
Targeting CXCL13 During Neuroinflammation.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Fatigue and sleep disturbance in multiple sclerosis.
Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Vitamin D and multiple sclerosis.
Jacksonian seizure as the relapse symptom of multiple sclerosis.
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment.
New data identify an increasing sex ratio of multiple sclerosis in Sweden.
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
Symptomatic Thoracic Spinal Cord Herniation: Case Series and Technical Report.
What is new in MS spasticity research? Poster session highlights.
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Loss of Allograft inflammatory factor-1 ameliorates experimental autoimmune encephalomyelitis by limiting encephalitogenic CD4 T cell expansion.
Clinical data and regulatory issues of biosimilar products.
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
Subgroup analysis in MS trials.
Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?

Pages